Online Only - BioPharm International

ADVERTISEMENT

Online Only

Sanofi Pasteur's High-Dose Flu Vaccine Shows Superior Clinical Benefit in Older Adults

August 28, 2013

A Sanofi Pasteur flu-vaccine trial in adults 65 years of age and older meets a primary endpoint for superior efficacy.

European Biochemical Engineering Society Sets Vision

July 9, 2013

The new organization hopes to enhance quality of life in Europe with advancements in biochemical engineering sciences.

Immunocore Collaborates with GlaxoSmithKline on T-Cell Receptor Technology

July 9, 2013

Research will focus on cancer and viral disease targets not addressable using antibody-based technologies.

Base4 and Hitachi High-Tech Collaborate on Developing Novel Nanopore DNA-Sequencing System

July 8, 2013

The core DNA-sequencing technology is based on the concept of passing a single strand of DNA through a nanometer-scale pore and reading out the sequence directly as it does so.

Novartis and Biological E Collaborate on Delivering Affordable Vaccines

July 8, 2013

Novartis and Biological E, a biopharmaceutical company based in India, have entered into an agreement that aims to deliver affordable and accessible vaccines for typhoid and paratyphoid A fevers to developing countries and thereby address the unmet medical need in endemic regions.

Seattle Genetics Forms ADC Pact with Bayer

July 3, 2013

Seattle Genetics could potentially receive approximately $500 million in fees, milestones and royalties.

National Institutes of Health Funds Projects to Identify New Uses for Existing Compounds

June 24, 2013

NIH awards $12.7 million for collaborations between nine academic research groups and pharmaceutical industry partners to explore new treatments.

Sandoz Launches Phase III Clinical Trial for Biosimilar Etanercept

June 24, 2013

Global program seeks to confirm biosimilarity to support regulatory submissions in the US and EU.

RAME-HART Technology Helps Boost Vaccine Production in Emerging Markets

June 19, 2013

Semi-automatic technology aids egg-based influenza vaccine production in smaller facility footprints.

ADVERTISEMENT

ADVERTISEMENT

Click here